Jefferson University Hospitals

Physician Profile

Walter Kraft, MD

Jefferson University Physician

Academic Title: Associate Professor
Director, Clinical Research Unit and Division of Clinical Pharmacology

Specialties
Clinical Pharmacology (Not Accepting New Patients)
Vascular Medicine (Not Accepting New Patients)

Office Locations

Philadelphia
Gibbon Bldg., Ste. 6270
111 S. 11th Street
Philadelphia PA 19107
Phone: (215) 955-6540
Fax: (215) 923-0835

Medical Services

Board Certifications

  • Internal Medicine
  • Clinical Pharmacology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

United States Pharmacopeia, Medical School Representative

Governing Board Member, American Board of Clinical Pharmacology 2010,2009,2008,2007

Golden Apple Teaching Award, Thomas Jefferson University Hospital Internal Medicine Residency 2008

Top 25 Most Highly Rated Teachers, Thomas Jefferson University Hospital Internal Medicine Residency 2008

Jefferson Medical College Early Career Investigator Award for Distinguished Achievement in Biomedical Research 2010

Education

  • University of Pittsburgh, Medical School

Internship

  • Thomas Jefferson University Hospital

Residency

  • Thomas Jefferson University Hospital

Fellowship

  • Thomas Jefferson University Hospital

Recent Publications

Medication Complications in Extracorporeal Membrane Oxygenation

The authors reply

Buprenorphine for the treatment of the neonatal abstinence syndrome

Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention

Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: A cohort study

Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects

Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

Pharmacologic and clinical evaluation of posaconazole

Ethanol Pharmacokinetics in Neonates and Infants

Posaconazole tablet pharmacokinetics: Lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

Poor positive predictive value of McConnell's sign on transthoracic echocardiography for the diagnosis of acute pulmonary embolism.

Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: Is there a proven role?

Limited Sampling Estimates of Epigallocatechin Gallate Exposures in Cirrhotic and Noncirrhotic Patients With Hepatitis C After Single Oral Doses of Green Tea Extract

MK-0448, a specific Kv1.5 inhibitor safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humans

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients

Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis

Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease